BlackRock Fund Advisors’s Lifecore Biomedical LFCR Stock Holding History

BlackRock Fund Advisors’s Portfolio LFCR Stock Details LFCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$12.1M	Buy	875,895 +132,311	+18%	+$1.83M	﹤0.01%	2467
2016 Q3	$9.97M	Buy	743,584 +49,543	+7%	+$600K	﹤0.01%	2473
2016 Q2	$7.47M	Buy	694,041 +4,878	+0.7%	+$53.8K	﹤0.01%	2578
2016 Q1	$7.24M	Sell	689,163 -21,348	-3%	-$234K	﹤0.01%	2538
2015 Q4	$8.4M	Buy	710,511 +30,082	+4%	+$369K	﹤0.01%	2539
2015 Q3	$7.94M	Sell	680,429 -9,020	-1%	-$120K	﹤0.01%	2517
2015 Q2	$9.95M	Sell	689,449 -33,603	-5%	-$485K	﹤0.01%	2503
2015 Q1	$10.1M	Sell	723,052 -11,497	-2%	-$159K	﹤0.01%	2439
2014 Q4	$10.1M	Buy	734,549 +99,864	+16%	+$1.29M	﹤0.01%	2454
2014 Q3	$7.78M	Sell	634,685 -35,190	-5%	-$439K	﹤0.01%	2496
2014 Q2	$8.37M	Sell	669,875 -55,444	-8%	-$652K	﹤0.01%	2527
2014 Q1	$8.1M	Buy	725,319 +21,584	+3%	+$237K	﹤0.01%	2519
2013 Q4	$8.53M	Sell	703,735 -30,679	-4%	-$366K	﹤0.01%	2494
2013 Q3	$8.96M	Buy	734,414 +88,106	+14%	+$1.23M	﹤0.01%	2441
2013 Q2	$8.54M	Buy	+646,308	New	+$8.94M	﹤0.01%	2349

Other funds holding LFCR

NIMC

NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

TAM

THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BlackRock Fund Advisors's LFCR Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Lifecore Biomedical (LFCR) stake by 18% in Q4 2016, buying an estimated $1.83M and bringing the position to 875,895 shares worth $12.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2467.

BlackRock Fund Advisors first reported a position in LFCR in Q2 2013 and has held it in 15 quarters since. 93 funds tracked by Wall St. Rank hold LFCR as of Q4 2016.

BlackRock Fund Advisors held 875,895 shares of Lifecore Biomedical worth $12.1M as of Q4 2016.
BlackRock Fund Advisors bought 132,311 Lifecore Biomedical shares in Q4 2016, an estimated $1.83M.
Lifecore Biomedical made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #2467 holding.
BlackRock Fund Advisors first reported a position in Lifecore Biomedical in Q2 2013 and has held it in 15 quarters since.
93 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.